ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2959

Patterns of Vascular Brain Injury in Systemic Lupus Erythematosus Patients with Ischemic Stroke: Impact on Neuropsychological, Neurobehavioral and Physical Function Outcome

Jamal A. Mikdashi1, Marcia Wozniak2, Umran Ashraf3 and William Regenold4, 1Div of Rheumatology, Univ of Maryland Schl of Med, Baltimore, MD, 2Neurology, University of Maryland School of Medicine, Baltimore, MD, 3Radiology, University fo Maryland, Baltimore, MD, 4Psychiatry, Univeristy of Maryland School of Medicine, Baltimore, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cognitive dysfunction, depression, physical impairment and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ischemic strokes in Systemic lupus erythematosus (SLE) patients contribute to increased morbidity and mortality.  Little is known however, about the patterns of ischemic brain injury in SLE and how this issue impacts the clinical outcome. Our objective is to investigate the neuropsychological, neurobehavioral and physical function in SLE patients with ischemic stroke, and correlate findings with the type of arterial ischemic injury.

Methods: Consecutive SLE patients presented with first-ever ischemic stroke drawn from the Maryland Lupus Cohort from 2000 to 2014 were observed.  Ischemic brain injury was categorized based on brain magnetic resonance imaging (MRI/ MRA) into infarctions of large territorial, lacuanar, localized cortical and borderzone. Angiographic findings were staged to assess severity of arterial stenotic lesion. Comparison was made to age- and gender -matched SLE patients with no stroke, and non SLE ischemic stroke subjects. Primary outcomes determined at 6 months post stroke included, cognitive dysfunction, mood disorders, emotion/ affective disorders and physical function.

Results: 56 SLE patients with stroke (mean age 35.7 years, 82 % women, 84 % African American, mean duration of SLE 5.5 years), 44 SLE patients with no stroke (mean age 32.9 years, 93 % women, 77 % African American, mean duration of SLE 6.5 years ) and 20 Non SLE stroke subjects (mean age  37.5 years, 80 % women, 90 % African American) were included. There was no significant statistical difference among the three groups regarding demographic and clinical features, phospholipid syndrome, disease activity, co-morbid conditions, treatment or stroke rehabilitation care.

Poor cognitive performance in SLE patients with stroke was frequently associated with subcortical damage with and without white matter intensity ( p value < 0.003), as compared to major cortical syndrome in non SLE stroke subjects (P value < 0.010), after adjusting for vascular risk factors.  Cognitive domains of memory, orientation, language, and attention were more defective in SLE patients with stroke when compared with SLE patients with no stroke or non SLE stroke subjects.

Post stroke depression and emotional incontinence were associated with cognitive impairment among SLE patients with stroke and non SLE stroke subjects, regardless of coping style, anti-depressant intake, severity of steno-occlusive disease, or phospholipid syndrome.  Post stroke depression was associated with cortical (OR: 1.5, 95 % CI: 1.0- 2.7), and subcortical lesions (OR: 12.0, 95 % CI: 1.8-78.2) among SLE patients, compared to right hemispheric lesion (OR: 1.2, 95 % CI: 1.0- 2.6) in non SLE stroke subjects.

Functional impairment was greater among SLE patients with focal brain injury (OR: 2.2, 95% CI: 1.1-25.6), and those with cognitive impairment (OR: 3.0, 95% CI: 1.7- 14.8), after adjusting for co-morbid condition and severity of stroke.

Conclusion: Ischemic brain injury in SLE is associated with cognitive impairment, depression, emotional incontinence and physical disability.  Better understanding of the mechanism of vascular brain injury in SLE will improve patient care and facilitate the development of therapeutic options and effective rehabilitative measures.


Disclosure: J. A. Mikdashi, None; M. Wozniak, None; U. Ashraf, None; W. Regenold, None.

To cite this abstract in AMA style:

Mikdashi JA, Wozniak M, Ashraf U, Regenold W. Patterns of Vascular Brain Injury in Systemic Lupus Erythematosus Patients with Ischemic Stroke: Impact on Neuropsychological, Neurobehavioral and Physical Function Outcome [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/patterns-of-vascular-brain-injury-in-systemic-lupus-erythematosus-patients-with-ischemic-stroke-impact-on-neuropsychological-neurobehavioral-and-physical-function-outcome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patterns-of-vascular-brain-injury-in-systemic-lupus-erythematosus-patients-with-ischemic-stroke-impact-on-neuropsychological-neurobehavioral-and-physical-function-outcome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology